|Day's Range||0.00 - 0.00|
|52 Week Range|
|PE Ratio (TTM)||-0.52|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||2.50|
FluoroPharma Medical Inc. announced today that it has been collaborating with Philips for data management in conjunction with its Phase II clinical trials for its lead agent CardioPET . Safety and image ...
FluoroPharma Medical Inc. announced today that data from its Phase II clinical trial for CardioPET were presented at the 21st Annual Meeting of the American Society of Nuclear Cardiology on September 24th, ...
FluoroPharma Medical, Inc. today announced that the company will conduct a conference call with the investment community, scheduled at 4:30 p.m. EDT on Wednesday, June 22, 2016. The objectives of the call ...